Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Description of the Business and Liquidity (Details)

v2.4.0.8
Note 1 - Description of the Business and Liquidity (Details) (USD $)
 1 Months Ended 9 Months Ended 12 Months Ended 1 Months Ended 6 Months Ended
Mar. 31, 2014
Jan. 31, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2014
Boston Scientific Notes [Member]
Jun. 30, 2014
Boston Scientific Notes [Member]
Note 1 - Description of the Business and Liquidity (Details) [Line Items]                
Retained Earnings (Accumulated Deficit)     $ (75,362,522)   $ (72,752,602)      
Net Cash Provided by (Used in) Operating Activities     (5,256,287) (6,263,800) (7,777,931)      
Proceeds from Issuance of Private Placement 3,503,314 9,829,014            
Notes Payable Cancelled, Principal Amount             4,338,601 4,338,601
Cash and Cash Equivalents, at Carrying Value     $ 1,894,681 $ 5,031,199 $ 3,516,244 $ 1,620,005